cefepime hospira süste-/infusioonilahuse pulber
hospira uk limited - tsefepiim - süste-/infusioonilahuse pulber - 2g 20ml 5tk; 2g 20ml 10tk; 2g 20ml 1tk
cefepime hospira süste-/infusioonilahuse pulber
hospira uk limited - tsefepiim - süste-/infusioonilahuse pulber - 1g 20ml 5tk
cefepime norameda süste-/infusioonilahuse pulber
norameda uab - tsefepiim - süste-/infusioonilahuse pulber - 1g 10tk
cefepime mip süste-/infusioonilahuse pulber
mip pharma gmbh - tsefepiim - süste-/infusioonilahuse pulber - 1g 10tk; 1g 5tk
cefepime mip süste-/infusioonilahuse pulber
mip pharma gmbh - tsefepiim - süste-/infusioonilahuse pulber - 2g 5tk; 2g 10tk; 2g 1tk
cefepime süstelahuse pulber
acs dobfar s.p.a. (addetta plant) - tsefepiim - süstelahuse pulber - 1000mg 1000mg 1tk
maxipime süste-/infusioonilahuse pulber
bristol-myers squibb gyogyszerkereskedelmi kft. - tsefepiim - süste-/infusioonilahuse pulber - 2000mg 1tk
alphacef süste-/infusioonilahuse pulber
medochemie limited - tsefepiim - süste-/infusioonilahuse pulber - 1g 15ml 10tk; 1g 15ml 50tk
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials süsteemseks kasutamiseks, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.